Besides that, we discovered that the combined application of these treatments can significantly reduce the expression of NSUN2, ultimately partially preventing the uncontrolled evolution of HCC, suggesting a treatment strategy with promising clinical application potential. The gene discussed is NSUN2; the disease is hepatocellular carcinoma.